Antacids are commonly used drugs that help neutralize stomach acidity, providing relief from heartburn, indigestion, and upset stomach.
However, recent research conducted by scientists from the University of Maryland suggests that antacids can also have a positive impact on blood sugar control in individuals with diabetes.
With type 2 diabetes being a significant global health concern, affecting nearly 10 percent of the population worldwide, this study sheds light on a potential new approach to managing glucose levels alongside standard diabetes care.
Antacids as an Adjunct Therapy
Standard care for diabetes typically involves dietary and lifestyle changes, along with prescribed diabetes medications or insulin.
However, the University of Maryland study discovered that adding antacids to standard therapy yielded superior results in reducing hemoglobin A1c (HbA1c) levels and fasting blood sugar in individuals with diabetes.
This suggests that antacids could be used as an additional tool to improve glucose control in diabetic patients.
Effects on Blood Sugar Levels
The research team conducted a meta-analysis focusing on proton pump inhibitors (PPIs), a commonly used type of antacid medication.
They examined the effects of PPIs on blood sugar levels in individuals with diabetes and whether these medications could prevent the onset of diabetes in the general population.
The analysis included seven studies involving 342 participants to assess glycemic control and five studies involving 244,439 participants to evaluate the risk of incident diabetes.
Positive Results for Diabetes Management
Based on the meta-analysis, the team found that antacids, specifically PPIs, reduced HbA1c levels by an average of 0.36% and lowered fasting blood sugar levels by 10 mg/dl in individuals with diabetes, as evidenced by the results of seven clinical trials.
However, for individuals without diabetes, the studies showed that antacids had no significant effect on reducing the risk of developing the disease.
Implications and Recommendations
The research team emphasizes that individuals with diabetes should be aware of the potential glucose-lowering effect of commonly used antacid medications.
Healthcare providers may also consider this when prescribing antacids to their patients, keeping in mind their potential benefit in improving blood sugar control.
However, it is important to note that antacids should be seen as an adjunct therapy and not a replacement for standard diabetes care.
The study conducted by Carol Chiung-Hui Peng et al., published in the Journal of Clinical Endocrinology & Metabolism, reveals a surprising finding that antacids, specifically PPIs, can contribute to better blood sugar control in individuals with diabetes.
While antacids do not appear to have a preventive effect on the development of diabetes in those without the condition, they offer a potential adjunct therapy for managing glucose levels in individuals with diabetes.
As further research unfolds, it is hoped that healthcare providers will consider the glucose-lowering effect of antacids when tailoring treatment plans for their diabetic patients, ultimately improving their overall diabetes management.
If you care about diabetes, please read studies about berries that can help prevent diabetes, obesity, and cancer, and new drugs to treat diabetes and metabolic syndrome.
For more information about diabetes, please see recent studies about the normal blood sugar for people with diabetes, results showing that Zinc may be the key to better diabetes treatments.
Copyright © 2023 Knowridge Science Report. All rights reserved.
